Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Fred Levine who wrote (1988)	2/10/2002 5:53:12 PM
From: dwight martin	Read Replies (2) of 2515

In the local Austin newspaper there is the story of a Mrs. Topfer who had pancreatic cancer two years ago but was able to get into an Erbitux trial. Just FWYTIMBW. I have never had any interest in IMCL. austin360.com "I told the oncologist when I first met him, that when I came to this hospital, I had a benign tumor that needed to be removed," she recalled. "Now I'm being told that I have inoperable, terminal cancer, and I don't accept it. It's as simple as that." (Ed. - Gee, if only . . . .) She insisted on having a hysterectomy to remove her ovaries. After that surgery, in November 2000, she was accepted into an experimental drug program at M.D. Anderson. The drug was Erbitux, which along with another drug, stopped the growth of her tumor. Erbitux has been in the headlines recently, * * * leaving little hope Erbitux will be approved in the near future."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next